Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes

Regulatory Peptides - Tập 122 - Trang 209-217 - 2004
Michael A. Nauck1,2, Andrea El-Ouaghlidi2, Bartholomäus Gabrys1, Katrin Hücking1, Jens J. Holst3, Carolyn F. Deacon3, Baptist Gallwitz1, Wolfgang E. Schmidt1, Juris J. Meier1,4
1Medizinische Klinik 1, St. Josef-Hospital, Ruhr-Universität Bochum, Bochum D-44791, Germany
2Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz D-37431, Germany
3Department of Medical Physiology, Panum Institute, University of Copenhagen, Copenhagen DK-2200, Denmark
4Larry Hillblom Islet Research Center, UCLA School of Medicine, 24-130 Warren Hall, 900 Veteran Avenue, Los Angeles, CA 90095, USA

Tài liệu tham khảo

Creutzfeldt, 1979, The incretin concept today, Diabetologia, 16, 75, 10.1007/BF01225454

Creutzfeldt, 1992, Gut hormones and diabetes mellitus, Diabetes/Metab. Rev, 8, 149, 10.1002/dmr.5610080206

Nauck, 1993, Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7–36) amide infused at near-physiological insulinotropic hormone and glucose concentrations, J. Clin. Endocrinol. Metab, 76, 912, 10.1210/jc.76.4.912

Kreymann, 1987, Glucagon-like peptide-1 [7–36]: a physiological incretin in man, Lancet, 2, 1300, 10.1016/S0140-6736(87)91194-9

Nauck, 1986, Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses, J. Clin. Endocrinol. Metab, 63, 492, 10.1210/jcem-63-2-492

Nauck, 1986, Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes, Diabetologia, 29, 46, 10.1007/BF02427280

Crockett, 1976, Gastric inhibitory peptide (GIP) in maturity-onset diabetes mellitus, Diabetes, 25, 931, 10.2337/diabetes.25.10.931

Jones, 1989, The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia, 32, 668, 10.1007/BF00274255

Amland, 1985, Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state, Scand. J. Gastroenterol, 20, 315, 10.3109/00365528509091657

Jones, 1987, The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion, Diabetologia, 30, 707, 10.1007/BF00296993

Krarup, 1988, Effect of porcine gastric inhibitory polypeptide on β-cell function in Type 1 and Type II diabetes mellitus, Metabolism, 36, 677, 10.1016/0026-0495(87)90153-3

Nauck, 1993, Preserved incretin activity of glucagon-like peptide 1 [7–36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus, J. Clin. Invest, 91, 301, 10.1172/JCI116186

Vilsbøll, 2002, Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients, Diabetologia, 45, 1111, 10.1007/s00125-002-0878-6

Toft-Nielsen, 2001, Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients, J. Clin. Endocrinol. Metab, 86, 3717, 10.1210/jc.86.8.3717

Vilsbøll, 2001, Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients, Diabetes, 50, 609, 10.2337/diabetes.50.3.609

Meier, 2001, Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with Type 2 diabetes, Diabetes, 50, 2497, 10.2337/diabetes.50.11.2497

Köbberling, 1985, Genetics of type 2 A- and type 2 B-diabetes mellitus (abstract), Diabetes Res. Clin. Pract, 1, 311

Ward, 1984, Diminished B cell secretory capacity in patients with non-insulin-dependent diabetes mellitus, J. Clin. Invest, 74, 1318, 10.1172/JCI111542

Nauck, 1998, 101

Meier, 2002, Gastric inhibitory polypeptide: the neglected incretin revisited, Regul. Pept, 107, 1, 10.1016/S0167-0115(02)00039-3

Perley, 1967, Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects, J. Clin. Invest, 46, 1954, 10.1172/JCI105685

Tillil, 1988, Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans, Am. J. Physiol., Endocrinol. Metab, 254, E349, 10.1152/ajpendo.1988.254.3.E349

Nauck, 2001, Quantification of the incretin effect in first-degree relatives of Type 2 diabetic patients compared to healthy control subjects (abstract), Diabetologia, 44, A 195

Deacon, 2000, Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide, J. Clin. Endocrinol. Metab, 85, 3575, 10.1210/jc.85.10.3575

Nauck, 1997, Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans, Am. J. Physiol, 273, E981

Mitrakou, 1992, Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance, N. Engl. J. Med, 326, 22, 10.1056/NEJM199201023260104

Nyholm, 1999, Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of type II (non-insulin-dependent) diabetic parents: evidence of several aberrations, Diabetologia, 42, 1314, 10.1007/s001250051444

Clark, 1989, Studies of the entero-insular axis following pancreas transplantation in man: neural or hormonal control?, Diabet. Med, 6, 813, 10.1111/j.1464-5491.1989.tb01285.x

Nauck, 1993, Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation, Acta Diabetol, 30, 39, 10.1007/BF00572873

Nauck, 1989, Insulinotropic properties of synthetic gastric inhibitory peptide in man: interactions with glucose, phenylalanin, and cholezystokinin-8, J. Clin. Endocrinol. Metab, 69, 654, 10.1210/jcem-69-3-654

Vilsbøll, 2003, Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects, Regul. Pept, 114, 115, 10.1016/S0167-0115(03)00111-3

Meier, 2003, Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes, J. Clin. Endocrinol. Metab, 88, 2719, 10.1210/jc.2003-030049

Meier, 2003, Gastric inhibitory polypeptide (GIP) does not inhibit gastric emptying in man, Am. J. Physiol., Endocrinol. Metab, 286, E621, 10.1152/ajpendo.00499.2003

Fritsche, 2000, Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion, Diabetologia, 43, 852, 10.1007/s001250051461

Van Haeften, 1991, Decreased insulin secretory capacity and normal pancreatic B-cell glucose sensitivity in non-obese patients with NIDDM, Eur. J. Clin. Investig, 21, 168, 10.1111/j.1365-2362.1991.tb01806.x

Meier, 2003, Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects, Metabolism, 52, 1579, 10.1016/S0026-0495(03)00327-5

Brubaker, 1991, Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides, Endocrinology, 128, 3175, 10.1210/endo-128-6-3175

Herrmann-Rinke, 1995, Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides, J. Endocrinol, 147, 25, 10.1677/joe.0.1470025

Fieseler, 1995, Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8, Am. J. Physiol, 268, E949

Mortensen, 2001, The incretin hormones GLP-1 and GIP are partly colocalized in the gut in man, pig and rat (abstract), Diabetes, 50, A 311

Damholt, 1999, Immonocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine, Cell Tissue Res, 298, 287, 10.1007/s004419900093

Mortensen, 2003, GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine, Regul. Pept, 114, 189, 10.1016/S0167-0115(03)00125-3

Eissele, 1992, Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man, Eur. J. Clin. Investig, 22, 283, 10.1111/j.1365-2362.1992.tb01464.x

Ørskov, 1989, Complete sequences of glucagon-like peptide-1 from human and pig small intestine, J. Biol. Chem, 264, 12826, 10.1016/S0021-9258(18)51561-1

Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883

Thông tin
Thông tin xuất bản

Regulatory Peptides

Tập 122

209-217

Thông tin tác giả